Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"the findings represent a 'pivotal moment' in the field of cancer research."
— Stephane Bancel , Executive
"the research 'shows promise' but said that the interim data still needs to be fully reviewed."
— Dr Talisia Quallo , Academic
"'This is certainly good news for patients with melanoma, but the study has much wider implications.'"
— Dr Lennard Lee , Academic
Key People
Dr Lennard Lee is a consultant medical oncologist and associate professor at the University of Oxford.
Dr Talisia Quallo is the head of prevention and early detection at Cancer Research UK.
Stephane Bancel is the chief executive of Moderna.
Locations
All Coverage
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
Similar Stories
Related coverage based on topic and tags
Questions remain over Ebola patient who travelled across three nations undetected
Fresh details reveal how the 40-year-old businessman flew and crossed regional borders while seriously ill.
October 10, 2026 at 12:00 AMGP 10-minute appointment slots 'making it harder to do cancer checks'
Dr Amara Naseem says appointment times are not long enough to get the information she needs.
October 5, 2026 at 09:01 PMUS appeals court weighs block on Kennedy's vaccine panel appointments - Reuters
US appeals court weighs block on Kennedy's vaccine panel appointments Reuters
October 6, 2026 at 06:41 PMCancer patient hit with £680 in parking charges
Jeremy received four parking notices at Queen Alexandra Hospital after his free exemption expired.
October 6, 2026 at 05:05 PM'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
October 10, 2026 at 06:16 AMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PM